Author profile Richard Taylor, BSc, hide first letter Clinical Articles / October 2006 Insulin therapy is no cheaper than thiazolidinedione therapy in patients with type 2 diabetes Background Diabetes mellitus is a chronic metabolic disease affecting more than 2 million Canadians, and its prevalence is expected to rise to 3 million by the year 2010.[1] Approximately 85% to 90% of... Read More
Clinical Articles / October 2006 Insulin therapy is no cheaper than thiazolidinedione therapy in patients with type 2 diabetes Background Diabetes mellitus is a chronic metabolic disease affecting more than 2 million Canadians, and its prevalence is expected to rise to 3 million by the year 2010.[1] Approximately 85% to 90% of... Read More